CD33 and Alzheimer disease: Neuropathological studies have shown the presence of activated microglia and inflammation related mediators in AD brains of low Braak stage [81], while genetic studies show that several genes that increase the risk of sporadic AD encode factors that regulate microglial clearance of misfolded proteins and inflammatory reaction, such as TREM2 and CD33 [82, 83].